INIS
patients
100%
safety
100%
steroids
100%
cyclophosphamide
100%
cyclosporine
100%
drugs
50%
comparative evaluations
50%
side effects
50%
kidneys
50%
children
25%
diseases
25%
populations
25%
gums
25%
creatinine
25%
allocations
25%
Pharmacology, Toxicology and Pharmaceutical Science
Steroids
100%
Cyclophosphamide
100%
Prospective Study
100%
Nephrotic Syndrome
100%
Ciclosporin
100%
Tacrolimus
100%
Calcineurin Inhibitor
44%
Remission
33%
Congenital Nephrotic Syndrome
33%
Side Effect
22%
Adverse Effect of Drug
22%
Drug
11%
Diseases
11%
Creatinine
11%
Survival
11%
Hyperplasia
11%
Mycophenolate Mofetil
11%
Medicine and Dentistry
Cyclophosphamide
100%
Steroid
100%
Cyclosporine
100%
Tacrolimus
100%
Nephrotic Syndrome
100%
Calcineurin Inhibitor
44%
Patient
33%
Spontaneous Remission
33%
Therapeutic Procedure
22%
Side Effect
22%
Drug
11%
Chemotherapeutic Agent
11%
Disease
11%
Serum
11%
Creatinine
11%
Inpatient
11%
Child
11%
Survival
11%
Childhood
11%
Kidney Function
11%
Hyperplasia
11%
Mycophenolate Mofetil
11%
Hypertrichosis
11%